Altogen Labs extensive biotechnology and pharmacology research services include the following:

News

Altogen Labs Launches In Vivo siRNA Liposome Encapsulation Services /12.12.2011

Altogen Labs launched siRNA liposome encapsulation service, a laboratory technique to enable in vivo delivery of siRNA. Liposome encapsulation platform uses latest microfluidizer (Microfluidics) technology and is unique in its ability to achieve liposomal protection of functional siRNA molecules, provide uniform target particle sizes, and enhance siRNA transfection efficiency in vivo Read

Altogen Labs Company Profile /08.11.2011

Altogen Labs, a GLP-compliant laboratory located in Austin, Texas (USA), provides pharmacology and biotechnology contract research services (CRO). Company offers innovative life science research services, including a variety of pre-clinical studies, development of stable cell lines, in vivo biodistribution, xenograft and RNAi gene silencing services - siRNA encapsulation, targeting Read

Altogen Labs Launches Pyrosequencing Services /19.07.2011

Altogen Labs, a biology contract research organization and provider of pre-clinical research services, announced its launch of a pyrosequencing service today. Based on the new PyroMark platform, the pyrosequencing service is a multi-application genetic analysis tool Read

Texas-Based Biotechnology Company Develops Oil-Degrading Bacteria /24.10.2010

Altogen Labs announced today that it has successfully isolated natural oil-eating bacteria from polluted soil near Galveston Bay, Texas that has been shown in laboratory tests to be effective for the bioremediation of crude oil and petroleum saturated earth. Read

PEG-Liposome siRNA In Vivo Transfection Kit From Altogen /21.10.2010

Altogen announced the release of its second generation of in vivo RNAi transfection reagent in the company's popular in vivo delivery product line: PEG-Liposome siRNA In Vivo Transfection Kit. This reagent is compatible for in vivo transfection of other negatively charged molecules – RNA, DNA, and small proteins. The company also offers custom encapsulation of target molecules Read

Altogen Launches Custom Biotechnology Research Services: Generation of Stable Cell Lines and RNAi Cell Transfection Services /11.03.2010

Altogen announced launch of new contract research services. Altogen custom services focus on providing specialized biotechnology and pharmaceutical services, including RNA Interference (RNAi) services, generation of stably-expressing cell lines, screening and transfection services Read

Altogen Launches Nanoparticle-based In Vivo Transfection Reagent /03.11.2009

Altogen announced launch of novel Nanoparticle-based transfection reagent for use in laboratories and research facilities for animal testing. Transfection is one of the major laboratory methods used to introduce DNA and RNA molecules into cells and tissues Read